Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Impact BioMedical, Inc. ( (IBO) ) has shared an announcement.
On November 5, 2025, Impact BioMedical Inc. held its annual meeting of stockholders, where 88.50% of the eligible shares were represented. During the meeting, stockholders approved the election of eight directors and ratified the appointment of Grassi & Co. as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Additionally, the compensation of the named executive officers was approved on an advisory basis.
More about Impact BioMedical, Inc.
Average Trading Volume: 204,136
Technical Sentiment Signal: Strong Sell
For detailed information about IBO stock, go to TipRanks’ Stock Analysis page.